Events picked up with the Fourth Universal Definition of MI were tied to higher mortality, emphasizing the role of ancillary ...

An appropriate duration of dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction that has been treated with guideline-recommended complete ...

Empagliflozin stabilizes kidney function and reduces heart failure risk post-myocardial infarction, with eGFR remaining stable over 24 months. The EMPACT-MI trial confirmed empagliflozin's safety when ...

Background: There are relatively few reports on the long-term sequential functional recovery and prognosis in patients with cerebellar infarction. The aim of this study was to investigate the ...

A new clinical practice guideline for the management of acute coronary syndromes (ACS), released today by the American College of Cardiology (ACC) and the American Heart Association (AHA), is backed ...

Myocardial ischemia is a drop in blood flow to the heart. Myocardial infarction, or heart attack, occurs when death or damage occurs in the muscle tissue of the heart due to low blood supply. The ...

Myocardial infarction is the most common form of cardiovascular disease worldwide, claiming over 9 million lives per year. As such, understanding the pathophysiology, epidemiology, signs, diagnostic ...

ABSTRACT: Background: A major cause of mortality and disability on a global scale is myocardial infarction (MI). These days, the most reliable way to detect and measure MI is via cardiovascular ...

After reading the article “Comments on the 2018 ESC Fourth Universal Definition of Myocardial Infarction”,1 we are prompted to comment on the diagnosis of type 4a acute myocardial infarction (AMI), ...

Among patients undergoing non-cardiac surgery more than 1 year after coronary drug-eluting stent (DES) implantation, there was no difference with respect to ischaemic outcomes or major bleeding ...